Source:http://linkedlifedata.com/resource/pubmed/id/20005184
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
A reversed-phase liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) method was developed and validated for simultaneous determination of ABT-888 and its major metabolite (M8) in human plasma. Sample preparation involved a liquid-liquid extraction by the addition of 0.25 ml of plasma with 10 microl of 1 M NaOH and 1.0 ml ethyl acetate containing 50 ng/ml of the internal standard zileuton. The analytes were separated on a Waters XBridge C(18) column using a gradient mobile phase consisting of methanol/water containing 0.45% formic acid at the flow rate of 0.2 ml/min. The analytes were monitored by tandem mass spectrometry with electrospray positive ionization. Linear calibration curves were generated over the ABT-888 and M8 concentration ranges of 1-2000 ng/ml in human plasma. The lower limits of quantitation (LLOQ) were 1 ng/ml for both ABT-888 and M8 in human plasma. The accuracy and within- and between-day precisions were within the generally accepted criteria for bioanalytical method (<15%). This method was successfully employed to characterize the plasma concentration-time profile of ABT-888 after its oral administration in cancer patients.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-((R)-2-methylpyrrolidin-2-yl)-1H-b...,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Poly(ADP-ribose) Polymerases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1873-376X
|
pubmed:author | |
pubmed:copyrightInfo |
2009 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
878
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-9
|
pubmed:meshHeading |
pubmed-meshheading:20005184-Benzimidazoles,
pubmed-meshheading:20005184-Calibration,
pubmed-meshheading:20005184-Chromatography, Liquid,
pubmed-meshheading:20005184-Drug Stability,
pubmed-meshheading:20005184-Enzyme Inhibitors,
pubmed-meshheading:20005184-Humans,
pubmed-meshheading:20005184-Poly(ADP-ribose) Polymerases,
pubmed-meshheading:20005184-Quality Control,
pubmed-meshheading:20005184-Reference Standards,
pubmed-meshheading:20005184-Tandem Mass Spectrometry,
pubmed-meshheading:20005184-Time Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.
|
pubmed:affiliation |
Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, N.I.H., Extramural
|